Apellis Pharmaceuticals Inc (APLS)
27.98
+0.72
(+2.64%)
USD |
NASDAQ |
Nov 01, 16:00
27.97
-0.01
(-0.04%)
After-Hours: 20:00
Apellis Pharmaceuticals Max Drawdown (5Y): 74.65% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
October 31, 2024 | 74.65% |
September 30, 2024 | 74.65% |
August 31, 2024 | 74.65% |
July 31, 2024 | 74.65% |
June 30, 2024 | 74.65% |
May 31, 2024 | 74.65% |
April 30, 2024 | 74.65% |
March 31, 2024 | 74.65% |
February 29, 2024 | 74.65% |
January 31, 2024 | 74.65% |
December 31, 2023 | 74.65% |
November 30, 2023 | 74.65% |
October 31, 2023 | 74.65% |
September 30, 2023 | 74.65% |
August 31, 2023 | 74.65% |
July 31, 2023 | 72.40% |
June 30, 2023 | 61.77% |
May 31, 2023 | 61.77% |
April 30, 2023 | 61.77% |
March 31, 2023 | 61.77% |
February 28, 2023 | 61.77% |
January 31, 2023 | 61.77% |
December 31, 2022 | 61.77% |
November 30, 2022 | 61.77% |
October 31, 2022 | 61.77% |
Date | Value |
---|---|
September 30, 2022 | 61.77% |
August 31, 2022 | 61.77% |
July 31, 2022 | 61.77% |
June 30, 2022 | 61.77% |
May 31, 2022 | 61.77% |
April 30, 2022 | 61.77% |
March 31, 2022 | 61.77% |
February 28, 2022 | 61.77% |
January 31, 2022 | 61.77% |
December 31, 2021 | 61.77% |
November 30, 2021 | 61.77% |
October 31, 2021 | 61.77% |
September 30, 2021 | 61.77% |
August 31, 2021 | 61.77% |
July 31, 2021 | 61.77% |
June 30, 2021 | 61.77% |
May 31, 2021 | 61.77% |
April 30, 2021 | 61.77% |
March 31, 2021 | 61.77% |
February 28, 2021 | 61.77% |
January 31, 2021 | 61.77% |
December 31, 2020 | 61.77% |
November 30, 2020 | 61.77% |
October 31, 2020 | 61.77% |
September 30, 2020 | 61.77% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
61.77%
Minimum
Nov 2019
74.65%
Maximum
Aug 2023
65.17%
Average
61.77%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
Biomarin Pharmaceutical Inc | 52.14% |
Ionis Pharmaceuticals Inc | 70.27% |
EyePoint Pharmaceuticals Inc | 93.95% |
Cassava Sciences Inc | 92.93% |
Macrogenics Inc | 93.69% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -15.09 |
Beta (5Y) | 0.8702 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 74.47% |
Historical Sharpe Ratio (5Y) | -0.0518 |
Historical Sortino (5Y) | -0.0747 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 30.13% |